Meredith Irwin Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• More is less: radiation exposure to family caregivers and health care providers of paediatric neuroblastoma patients receiving ¹³¹I-MIBG therapy in Canada — Poster Session 1 with wine & cheese
• A small molecule kinome inhibitor screen identifies the TGF-beta-activated kinase 1 (TAK1) as a target for combination therapy in MYC-driven neuroblastoma — Parallel 4 Novel Therapies and Immunotherapy
• Introduction, overview and goals — Workshop 4 - Next generation risk stratification: new approaches to identify highest risk patients (or ultra high risk patients)
• Panel Discussion — Workshop 4 - Next generation risk stratification: new approaches to identify highest risk patients (or ultra high risk patients)